The value of chlorhexidine gluconate wipes and prepacked washcloths to prevent the spread of pathogens-A systematic review

Australian Critical Care

Volumn 26, Issue 4, 2013, Pages 158-166

  Afonso, Elsa ^a,b   Llauradó, Mireia ^c,d   Gallart, Elisabeth ^b,e  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^d HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Chlorhexidine gluconate washcloths; Chlorhexidine gluconate wipes; Nosocomial infection prevention; Pathogens

Indexed keywords

CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; TOPICAL ANTIINFECTIVE AGENT;

ANALOGS AND DERIVATIVES; CROSS INFECTION; DEVICES; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT;

ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; CROSS INFECTION; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS;

EID: 84888349843     PISSN: 10367314     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aucc.2013.05.001     Document Type: Article

References (75)

1. Reducing harm to patients from health care associated infection: the role of surveillance 2008, 3. Australian Commission for Safety and Quality in Health Care. http://www.safetyandquality.gov.au/wp-content/uploads/2008/01/Reducing-Harm-to-Patient-Role-of-Surveillance1.pdf, M. Cruickshank, Ferguson J (Eds.).
2. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(Suppl. 4):S131-S138.
3. Burke J.P. Infection control - a problem for patient safety. N Engl J Med 2003, 348:651-656.
4. Hidron A.I., Edwards J.R., Patel J., et al. Participating national healthcare safety network facilities, NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention 2006-2007. Infect Control Hosp Epidemiol 2008, 29(11):996-1011. National Healthcare Safety Network Team.
5. Rosenberg A., Alatary S.D., Peterson A.F. Safety and efficacy of the antiseptic chlorhexidine gluconate. Surg Gynecol Obstet 1976, 143:789-792.
6. Hugo W.B., Longworth A.R. Some aspects of the mode of action of chlorhexidine. J Pharm Pharmacol 1964, 16:655-662.
7. McDonnell G., Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999, 12:147-179.
8. Harbison M.A., Hammer S.M. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. J Acquir Immune Defic Syndr 1989, 2:16-20.
9. Milstone A.M., Passaretti C.L., Perl T.M. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008, 46(2):274-281.
10. Wendt W., Schinke S., Wurttemberger M., et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomised, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2008, 28:1036-1043.
11. Climo M.W., Sepkowitz K.A., Zuccotti G., et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37(6):1858-1865.
12. Anderson R.L., Carr J.H., Bond W.W., et al. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol 1997, 18:195-199.
13. Goldenberg R.L., McClure E.M., Saleem S., et al. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol 2006, 107:1139-1146.
14. McClure E.M., Goldenberg R.L., Brandes N., et al. The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet 2007, 97:89-94. CHX Working Group.
15. Wilson C.M., Gray G., Read J.S., et al. Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET 025. J Acquir Immune Defic Syndr 2004, 35:138-143.
16. Gaynes R.P., Edwards J.R., Jarvis W.R., et al. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 1996, 98:357-361.
17. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
18. Baltimore R.S. Neonatal sepsis: epidemiology and management. Paediatr Drugs 2003, 5:723-740.
19. Milstone A.M., Bryant K.A., Huskins W.C., et al. The past, present, and future of healthcare-associated infection prevention in pediatrics: multidrug-resistant organisms. Infect Control Hosp Epidemiol 2010, 31(Suppl. 1):S18-S21.
20. Milstone A.M., Goldner B.W., Ross T., et al. Methicillin-resistant Staphylococcus aureus colonisation and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis 2011, 53(9):853-859.
21. Huang Y.C., Chou Y.H., Su L.H., et al. Methicillin-resistant Staphylococcus aureus colonisation and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006, 118:469-474.
22. Lee H.K., Lee W.G., Cho S.R. Clinical and molecular biological analysis of a nosocomial outbreak of vancomycin-resistant enterococci in a neonatal intensive care unit. Acta Paediatr 1999, 88:651-654.
23. Yuce A., Karaman M., Gulay Z., et al. Vancomycin-resistant enterococci in neonates. Scand J Infect Dis 2001, 33:803-805.
24. Malik R.M., Reale M.R., Li K., et al. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J 1999, 18:352-356.
25. Sohn A.H., Garrett D.O., Sinkowitz-Cochran R.L., et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001, 139:821-827.
26. Henning K.J., Delencastre H., Eagan J., et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 1996, 15:848-854.
27. Pacio G.A., Visintainer P., Maguire G., Wormser G.P., Raffalli J., Montecalvo M.A. Natural history of colonisation with vancomicina resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol 2003, 24:246-250.
28. Chapman A.K., Aucott S.W., Milstone A.M. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012, 32(1):4-9.
29. Tamma P.D., Aucott S.W., Milstone A.M. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010, 31(8):846-849.
30. Mullany L.C., Darmstadt G.L., Tielsch J.M. Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. Pediatr Infect Dis J 2006, 25(8):665-675.
31. Garland J.S., Alex C.P., Uhing M.R., et al. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009, 29(12):808-813.
32. Johnsson J., Seeberg S., Kjellmer I. Blood concentrations of chlorhexidine in neonates undergoing routine cord care with 4% chlorhexidine gluconate solution. Acta Paediatr Scand 1987, 76(4):675-676.
33. Pereira L., Chipato T., Mashu A., et al. Randomised study of vaginal and neonatal cleansing with 1% chlorhexidine. Int J Gynaecol Obstet 2011, 112(3):234-238.
34. Wilson C.M., Gray G., Read J.S., et al. Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET025. J Acquir Immune Defic Syndr 2004, 35(2):138-143.
35. Derde L.P., Dautzenberg M.J., Bonten M.J. Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 2012, 38(June (6)):931-939.
36. Eiselt D. Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical site infection in orthopaedic surgical patients. Orthop Nurs 2009, 28(3):141-145.
37. Karki S., Cheng A.C. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonisation with multi-resistant organisms: a systematic review. J Hosp Infect 2012, 82(2):71-84.
38. Ogrinc G., Mooney S.E., Estrada C., et al. The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care 2008, 17(Suppl. 1):i13-i32.
39. Murray M.R., Saltzman M.D., Gryzlo S.M., et al. Efficacy of preoperative home use of 2% chlorhexidine gluconate cloth before shoulder surgery. J Shoulder Elbow Surg 2011, 20(September (6)):928-933. [Epub 2011, May 25].
40. Cutland C.L., Madhi S.A., Zell E.R., et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet 2009, 374(9705):1909-1916.
41. Edmiston C.E., Seabrook G.R., Johnson C.P. Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control 2007, 35(2):89-96.
42. Kassakian S.Z., Mermel L.A., Jefferson J.A., et al. Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients. Infect Control Hosp Epidemiol 2011, 32(3):238-243.
43. Evans H.L., Dellit T.H., Chan J., Nathens A.B., et al. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. J.Arch Surg 2010, 145(3):240-246.
44. Montecalvo M.A., McKenna D., Yarrish R., et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med 2012, 125(5):505-511.
45. Popovich K.J., Hota B., Hayes R., et al. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009, 30(October (10)):959-963.
46. Bleasdale S.C., Trick W.E., Gonzalez I.M., et al. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007, 167(19):2073-2079.
47. Vernon M.O., Hayden M.K., Trick W.E., et al. Chicago Antimicrobial Resistance Project (CARP) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006, 166(3):306-311.
48. Milstone A.M., et al. Daily Chlorhexidine Gluconate Bathing Reduces Bacteremia in Critically Ill Children: Result from a Multicenter, Cluster Randomised, Controlled, Crossover Trial. Session: Oral Abstract Session, October 22 2011, [accessed 15.10.12].
49. Mullany L.C., Saha S.K., Shah R., et al. Impact of 4.0% chlorhexidine cord cleansing on the bacteriologic profile of the newborn umbilical stump in rural Sylhet District Bangladesh: a community-based, cluster-randomised trial. Pediatr Infect Dis J 2012, 31(5):444-450.
50. Bass P., Karki S., Rhodes D., Gonelli S., et al. Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonisation in hematology-oncology patients. Am J Infect Control 2013, 41(4):345-348.
51. Darmstadt G.L., Hossain M.M., Choi Y., et al. Safety and effect of chlorhexidine skin cleansing on skin flora of neonates in Bangladesh. Pediatr Infect Dis J 2007, 26(6):492-495.
52. Whitman T.J., Schlett C.D., Grandits G.A., et al. Chlorhexidine gluconate reduces transmission of methicillin-resistant Staphylococcus aureus USA300 among marine recruits. Infect Control Hosp Epidemiol 2012, 33(8):809-816.
53. Munoz-Price L.S., Dezfulian C., Wyckoff M., et al. Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Crit Care Med 2012, 40(5):1464-1469.
54. Bailey R.R., Stuckey D.R., Norman B.A., et al. Economic value of dispensing home-based preoperative chlorhexidine bathing cloths to prevent surgical site infection. Infect Control Hosp Epidemiol 2011, 32(5):465-471.
55. Lee A., Harlan R., Breaud A.R., et al. Blood concentrations of chlorhexidine in hospitalized children undergoing daily chlorhexidine bathing. Infect Control Hosp Epidemiol 2011, 32(4):395-397.
56. Whitman T.J., Herlihy R.K., Schlett C.D., et al. Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomised, double-blind, controlled effectiveness trial. Infect Control Hosp Epidemiol 2010, 31(12):1207-1215.
57. Coyer F.M., O'Sullivan J., Cadman N. The provision of patient personal hygiene in the intensive care unit: a descriptive exploratory study of bed-bathing practice. Aust Crit Care 2011, 24(3):198-209.
58. Edmiston C.E., Krepel C.J., Seabrook G.R., et al. Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission?. J Am Coll Surg 2008, 207(August (2)):233-239.
59. Edmiston C.E., Okoli O., Graham M.B., et al. Evidence for using chlorhexidine gluconate preoperative cleansing to reduce the risk of surgical site infection. AORN J 2010, 92(November (5)):509-518.
60. Johnson A.J., Daley J.A., Zywiel M.G., Delanois R.E., Mont M.A. Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty 2010, 25(Suppl. 6):98-102.
61. Ritz J., Pashnik B., Padula C., et al. Effectiveness of 2 methods of chlorhexidine bathing. J Nurs Care Qual 2012, 27(2):171-175.
62. Edgeworth J.D. Has decolonisation played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011, 66(Suppl. 2):ii41-ii47.
63. Saleem S., Rouse D.J., McClure E.M., et al. Chlorhexidine vaginal and infant wipes to reduce perinatal mortality and morbidity: a randomised controlled trial. Obstet Gynecol 2010, 115(6):1225-1232.
64. Moeslein S., Rajani P., Haggerty P. Horizontal reduction of hospital acquired infections in the intensive care unit by replacing bed baths with chlorhexidine impregnated cloths. Am J Inf Control 2011, 39(5):13-179. [presentation number].
65. Saleem S., Reza T., McClure E.M., et al. Chlorhexidine vaginal and neonatal wipes in home births in Pakistan: a randomised controlled trial. Obstet Gynecol 2007, 110(5):977-985.
66. Nelson R.E., Samore M.H., Smith K.J., et al. Cost-effectiveness of adding decolonisation to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect 2010, 16(12):1740-1746.
67. Caffrey A.R., Woodmansee S.B., Crandall N., et al. Low adherence to outpatient preoperative methicillin-resistant Staphylococcus aureus decolonisation therapy. Infect Control Hosp Epidemiol 2011, 32(9):930-932.
68. Rello J., Díaz E., Rodríguez A. Etiology of ventilator-associated pneumonia. Clin Chest Med 2005, 26(March (1)):87-95.
69. Torres A., Ewig S., Lode H., et al. European HAP working group defining, treating and preventing hospital acquired pneumonia: European perspective. Int Care Med 2009, 35(1):9-29.
70. Mullany L.C., Darmstadt G.L., Tielsch J.M. Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. Pediatr Infect Dis J 2006, 25:665-675.
71. Zupan J., Garner P., Omari A.A. Topical umbilical cord care at birth. Cochrane Database Syst Rev 2004, CD001057.
72. Mullany L.C., Darmstadt G.L., Tielsch J.M. Role of antimicrobial applications to the umbilical cord in neonates to prevent bacterial colonisation and infection: a review of the evidence. Pediatr Infect Dis J 2003, 22:996-1002.
73. Evens K., George J., Angst D., et al. Does umbilical cord care in preterm infants influence cord bacterial colonisation or detachment?. J Perinatol 2004, 24:100-104.
74. Oishi T., Iwata S., Nonoyama M., et al. Double-blind comparative study on the care of the neonatal umbilical cord using 80% ethanol with or without chlorhexidine. J Hosp Infect 2004, 58:34-37.
75. Shardell M., Harris A.S., El-Kamari S.S., et al. Statistical analysis and application of quasi-experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007, 45:901-907.